Neuronetics Announces Inducement Grant in Accordance with Nasdaq Listing Rule 5635(c)(4)

Inducement Awards Announcement: Neuronetics, Inc. has granted inducement awards in the form of restricted stock units (RSUs) to twelve new employees as part of their employment agreement, with vesting contingent on continued service with the company.

Details of RSUs: Each employee received a specific number of RSUs, with a vesting schedule that typically allows for one-third of the units to vest annually over three years, subject to the recipient's ongoing employment.

Company Overview: Neuronetics focuses on improving the quality of life for patients with neurohealth disorders through innovative treatments, including the NeuroStar Advanced Therapy, a non-invasive treatment for major depressive disorder (MDD).

Treatment Impact: The NeuroStar Advanced Therapy has delivered over 7.6 million treatments and is supported by extensive clinical data, while Greenbrook TMS treatment centers have provided more than 1.8 million treatments to patients struggling with depression.